Haldol

Haldol is the brand name for the antipsychotic medication haloperidol, supplied as an intramuscular injection in the European market. It belongs to the butyrophenone class of typical antipsychotics and works primarily as a dopamine D2 receptor antagonist. The product is prescription‑only and is used in clinical settings to manage severe psychiatric symptoms when rapid onset of action is required under medical supervision and individualized dosing.

Haldol intramuscular injection is indicated for several acute psychiatric conditions where rapid symptom control is essential.

- Schizophrenia, particularly acute exacerbations or when oral therapy is not feasible. - Acute psychosis associated with bipolar disorder or other mood disorders. - Manic episodes that require swift calming of severe agitation. - Severe agitation or aggression in hospitalized patients, including emergency settings. - Pre‑operative sedation for patients with known psychotic disorders.

Side effects of haloperidol injection vary in frequency and severity; they are categorized as common or serious based on clinical observations.

Common: - Drowsiness or sedation. - Dry mouth. - Constipation. - Extrapyramidal symptoms such as tremor or rigidity.

Serious: - Neuroleptic malignant syndrome, a rare but life‑threatening reaction. - Tardive dyskinesia, persistent involuntary movements. - Cardiac arrhythmias, including QT prolongation.

When prescribing Haldol, clinicians should evaluate patient history and monitor for specific risks to ensure safe use.

- History of cardiovascular disease or prolonged QT interval. - Parkinson’s disease or other movement disorders. - Elderly patients, especially those with dementia, due to increased sensitivity. - Severe hepatic or renal impairment may require dose adjustment. - Concomitant use of other dopamine‑blocking agents. - Pregnancy and breastfeeding status should be assessed.

Haloperidol can interact with other medications, affecting its efficacy or increasing the risk of adverse events.

Avoid: - Other antipsychotics or high‑potency dopamine antagonists. - Medications that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics). - Strong CYP3A4 inhibitors such as ketoconazole or clarithromycin.

Use with caution: - CNS depressants including benzodiazepines or opioids. - Anticholinergic agents, which may mask extrapyramidal symptoms. - Lithium, which can increase neurotoxic risk.